Literature DB >> 18222384

Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach?

Hiromichi Maeda1, Takehiro Okabayashi, Isao Nishimori, Takeki Sugimoto, Tsutomu Namikawa, Ken Dabanaka, Shigehiro Tsujii, Saburo Onishi, Michiya Kobayashi, Kazuhiro Hanazaki.   

Abstract

BACKGROUND: Although the incidence of gastric cardia cancer is considerably less than more distal gastric cancer, the rate of occurrence is now increasing. The objective of this study was to evaluate and compare the clinicopathologic findings of gastric cardia and more distal stomach adenocarcinoma. STUDY
DESIGN: Patients included in our study were those who underwent operations for gastric adenocarcinoma in our institute from 1981 to 2006, and who had undergone complete medical history, including history of daily alcohol consumption; smoking; body mass index; and pathologic examinations. A total of 843 patients were included in our study, and were divided into cardia and noncardia cancer groups.
RESULTS: Among the 843 patients, 23 (2.8%) had gastric cardia cancer. There were no substantial differences in age, gender, body mass index, smoking, or alcohol consumption between the two groups. Mean size of cardia tumors was larger than noncardia tumors. Although noncardia cancer was often detected at an early stage, gastric cardia cancer was most often diagnosed at an advanced stage. Pathologically, cardia cancer was more invasive and had more lymphatic permeation and lymph node metastasis than noncardia cancer.
CONCLUSIONS: Gastric cardia cancer occurs at a low incidence of only 2.8% of resected gastric cancers. Unlike cases of gastric cardia cancer in Western populations, body mass index is not associated with occurrence of gastric cardia cancer in our study. Because gastric cardia cancer appears more aggressive than noncardia gastric cancer, early diagnosis and intervention are important.

Entities:  

Mesh:

Year:  2007        PMID: 18222384     DOI: 10.1016/j.jamcollsurg.2007.06.306

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  23 in total

1.  Identification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data.

Authors:  Zhigang Wang; Zhi Yan; Bicheng Zhang; Zhiguo Rao; Yafei Zhang; Jian Liu; Lifang Yu; Yong Zhao; Bo Yang; Tingting Wu; Jianfei Gao
Journal:  Med Oncol       Date:  2013-08-03       Impact factor: 3.064

2.  Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma.

Authors:  H Dong; L Xie; C Tang; S Chen; Q Liu; Q Zhang; W Zheng; Z Zheng; H Zhang
Journal:  Clin Transl Oncol       Date:  2013-12-20       Impact factor: 3.405

3.  Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma.

Authors:  Eun Jeong Gong; Do Hoon Kim; Ji Yong Ahn; Kee Wook Jung; Jeong Hoon Lee; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Hee Sung Kim; In-Seob Lee; Beom Su Kim; Moon-Won Yoo; Sung Tae Oh; Jeong Hwan Yook; Byung Sik Kim
Journal:  Gastric Cancer       Date:  2016-12-19       Impact factor: 7.370

4.  Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma.

Authors:  Yuri Cho; Dong Ho Lee; Hong Sang Oh; Ji Yeon Seo; Dong Hyeon Lee; Nayoung Kim; Sook Hyang Jeong; Jin Wook Kim; Jin Hyuk Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin; Hyun Jin Jo; Hyun Chae Jung; Yong Bum Yoon; In Sung Song
Journal:  Dig Dis Sci       Date:  2012-04-07       Impact factor: 3.199

5.  Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer.

Authors:  Juliana Garcia de Oliveira; Ana Flávia Teixeira Rossi; Daniela Manchini Nizato; Aline Cristina Targa Cadamuro; Yvana Cristina Jorge; Marina Curado Valsechi; Larissa Paola Rodrigues Venâncio; Paula Rahal; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo; Ana Elizabete Silva
Journal:  Tumour Biol       Date:  2015-06-19

Review 6.  Aspirin use and the risk of gastric cancer: a meta-analysis.

Authors:  Ping Yang; Yong Zhou; Bo Chen; Hong-Wei Wan; Gui-Qing Jia; Hai-Long Bai; Xiao-Ting Wu
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

7.  Tumors of the gastroesophageal junction have intermediate prognosis compared to tumors of the esophagus and stomach, but share the same clinical determinants.

Authors:  Paolo G Gobbi; Manuela Bergonzi; Donatella Pozzoli; Lara Villano; Alessandro Vanoli; Franco Corbella; Paolo Dionigi; Gino R Corazza
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

8.  Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.

Authors:  Jeung Hui Pyo; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Kyoung-Mee Kim; Heejin Yoo; Soohyun Ahn; Jae J Kim
Journal:  Gastric Cancer       Date:  2017-12-14       Impact factor: 7.370

9.  Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China.

Authors:  Jiuda Zhao; Junhui Zhao; Feng Du; Yu Zhang; Guoshuang Shen; Haihong Zhu; Faxiang Ji; Fei Ma; Li Dong; Jie Kan; Fangchao Zheng; Hui Chen; Ziyi Wang; Binghe Xu
Journal:  J Gastrointest Surg       Date:  2016-02-01       Impact factor: 3.452

10.  Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.

Authors:  Ursula M Vogl; Laurenz Vormittag; Thomas Winkler; Alice Kafka; Olivia Weiser-Jasch; Bettina Heinrich; Sophie Roider-Schur; Haleh Andalibi; Eva Autzinger; Wolfgang Schima; Alexander Klaus; Johannes Zacherl; Günter Michael Wimberger; Leopold Öhler
Journal:  J Gastrointest Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.